Literature DB >> 31123982

Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.

Varun Haran1, Nibedita Lenka2.   

Abstract

Precise regulation of transcriptome modulates several vital aspects in an organism that includes gene expression, cellular activities and development, and its perturbation ensuing pathological conditions. Around 150 post-transcriptional modifications of RNA have been identified till date, which are evolutionarily conserved and likewise prevalent across RNA classes including messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), and detected less frequently in small nuclear RNA (snRNA) and microRNAs (miRNA). Among the RNA modifications documented, N6-methyladenosine (m6A) is the best characterised till date. Also, N1-methyladenosine (m1A), 5-methylcytosine (m5C) and pseudouridine (Ψ) are some of the other prominent modifications detected in coding and non-coding RNAs. "Epitranscriptome", ensemble of these post-transcriptional RNA modifications, precisely coordinates gene expression and biological processes. Current literatures suggest the critical involvement of epitranscriptomics in several organisms during early development, contributing to cell fate specification and physiology. Indeed, epitranscriptomics similar to DNA epigenetics involves combinatorial dynamics provided by modified RNA molecules and associated protein complexes, which function as "writers", "erasers" and "readers" of these modifications. A novel code orchestrating gene expression during cell fate determination is generated by the coordinated effects of different classes of modified RNAs and its regulator proteins. In this review, we summarize the current knowhow on N6-methyladenosine (m6A), 5-methylcytosine (m5C) and pseudouridine (ψ) modifications in RNA, the associated regulator proteins and enumerate how the epitranscriptomic regulations are involved in cell fate determination.

Entities:  

Keywords:  Cell fate; Embryonic development; Epitranscriptomics; Post-transcriptional modification; RNA binding protein; Stem cells

Mesh:

Substances:

Year:  2019        PMID: 31123982     DOI: 10.1007/s12015-019-09894-3

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  73 in total

1.  Pseudouridine, a carbon-carbon linked ribonucleoside in ribonucleic acids: isolation, structure, and chemical characteristics.

Authors:  W E COHN
Journal:  J Biol Chem       Date:  1960-05       Impact factor: 5.157

Review 2.  Mesoderm induction: from caps to chips.

Authors:  David Kimelman
Journal:  Nat Rev Genet       Date:  2006-05       Impact factor: 53.242

3.  RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage.

Authors:  Matthias Schaefer; Tim Pollex; Katharina Hanna; Francesca Tuorto; Madeleine Meusburger; Mark Helm; Frank Lyko
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

4.  Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons.

Authors:  Kate D Meyer; Yogesh Saletore; Paul Zumbo; Olivier Elemento; Christopher E Mason; Samie R Jaffrey
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

5.  The methylation state of poly A-containing messenger RNA from cultured hamster cells.

Authors:  D T Dubin; R H Taylor
Journal:  Nucleic Acids Res       Date:  1975-10       Impact factor: 16.971

6.  ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility.

Authors:  Guanqun Zheng; John Arne Dahl; Yamei Niu; Peter Fedorcsak; Chun-Min Huang; Charles J Li; Cathrine B Vågbø; Yue Shi; Wen-Ling Wang; Shu-Hui Song; Zhike Lu; Ralph P G Bosmans; Qing Dai; Ya-Juan Hao; Xin Yang; Wen-Ming Zhao; Wei-Min Tong; Xiu-Jie Wang; Florian Bogdan; Kari Furu; Ye Fu; Guifang Jia; Xu Zhao; Jun Liu; Hans E Krokan; Arne Klungland; Yun-Gui Yang; Chuan He
Journal:  Mol Cell       Date:  2012-11-21       Impact factor: 17.970

7.  Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA.

Authors:  Jeffrey E Squires; Hardip R Patel; Marco Nousch; Tennille Sibbritt; David T Humphreys; Brian J Parker; Catherine M Suter; Thomas Preiss
Journal:  Nucleic Acids Res       Date:  2012-02-16       Impact factor: 16.971

8.  MODOMICS: a database of RNA modification pathways.

Authors:  Stanislaw Dunin-Horkawicz; Anna Czerwoniec; Michal J Gajda; Marcin Feder; Henri Grosjean; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

9.  Yeast Rrp8p, a novel methyltransferase responsible for m1A 645 base modification of 25S rRNA.

Authors:  Christian Peifer; Sunny Sharma; Peter Watzinger; Stefanie Lamberth; Peter Kötter; Karl-Dieter Entian
Journal:  Nucleic Acids Res       Date:  2012-11-23       Impact factor: 16.971

10.  Temporal and contextual orchestration of cardiac fate by WNT-BMP synergy and threshold.

Authors:  Mahesh K Verma; Nibedita Lenka
Journal:  J Cell Mol Med       Date:  2010-05-11       Impact factor: 5.310

View more
  3 in total

1.  The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors.

Authors:  Vera Miranda-Gonçalves; João Lobo; Rui Henrique; Carmen Jerónimo; Catarina Guimarães-Teixeira; Daniela Barros-Silva; Rita Guimarães; Mariana Cantante; Isaac Braga; Joaquina Maurício; Christoph Oing; Friedemann Honecker; Daniel Nettersheim; Leendert H J Looijenga
Journal:  J Exp Clin Cancer Res       Date:  2021-08-25

2.  Brown Fat-Activating Lipokine 12,13-diHOME in Human Milk Is Associated With Infant Adiposity.

Authors:  Danielle Wolfs; Matthew D Lynes; Yu-Hua Tseng; Stephanie Pierce; Valerie Bussberg; Abena Darkwah; Vladimir Tolstikov; Niven R Narain; Michael C Rudolph; Michael A Kiebish; Ellen W Demerath; David A Fields; Elvira Isganaitis
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

Review 3.  Lactylation, an emerging hallmark of metabolic reprogramming: Current progress and open challenges.

Authors:  Xuelian Liu; Yu Zhang; Wei Li; Xin Zhou
Journal:  Front Cell Dev Biol       Date:  2022-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.